These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 32441311)
1. Human T cells interacting with HNSCC-derived mesenchymal stromal cells acquire tissue-resident memory like properties. Mazzoni A; Maggi L; Montaini G; Ramazzotti M; Capone M; Vanni A; Locatello LG; Barra G; De Palma R; Gallo O; Cosmi L; Liotta F; Annunziato F Eur J Immunol; 2020 Oct; 50(10):1571-1579. PubMed ID: 32441311 [TBL] [Abstract][Full Text] [Related]
2. Functional Heterogeneity of CD4 Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P Front Immunol; 2018; 9():2654. PubMed ID: 30505306 [TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of CD8 Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F Front Immunol; 2018; 9():1904. PubMed ID: 30158938 [TBL] [Abstract][Full Text] [Related]
4. Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma. Ida S; Takahashi H; Kawabata-Iwakawa R; Mito I; Tada H; Chikamatsu K Oral Oncol; 2021 Nov; 122():105508. PubMed ID: 34507204 [TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma. Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882 [TBL] [Abstract][Full Text] [Related]
7. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma. Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027 [TBL] [Abstract][Full Text] [Related]
8. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843 [TBL] [Abstract][Full Text] [Related]
9. Tissue-resident memory CD8 Wang T; Shen Y; Luyten S; Yang Y; Jiang X Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease. von Witzleben A; Ellis M; Thomas GJ; Hoffmann TK; Jackson R; Laban S; Ottensmeier CH Clin Cancer Res; 2024 Jan; 30(1):224-234. PubMed ID: 37874322 [TBL] [Abstract][Full Text] [Related]
11. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma. Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369 [TBL] [Abstract][Full Text] [Related]
12. Fatty Acid Oxidation Controls CD8 Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801 [TBL] [Abstract][Full Text] [Related]
13. Resident memory T cells, critical components in tumor immunology. Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905 [TBL] [Abstract][Full Text] [Related]
14. Cancer stem-like cells evade CD8 Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483 [TBL] [Abstract][Full Text] [Related]
15. Implication of CD69 Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061 [TBL] [Abstract][Full Text] [Related]
17. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer. Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850 [TBL] [Abstract][Full Text] [Related]
18. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma. Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583 [TBL] [Abstract][Full Text] [Related]
20. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy. Damei I; Trickovic T; Mami-Chouaib F; Corgnac S Front Immunol; 2023; 14():1205984. PubMed ID: 37545498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]